Inner Mongolia Huihuang Pharmaceutical Co., Ltd，established in January 2022, with a registered capital of 8 million yuan. The company adheres to the business philosophy of "people-oriented, green economy, and sustainable development", with the corporate spirit of "innovation, integrity, and responsibility". Based in the Yuanbao Mountain area of Chifeng City, Inner Mongolia, with a focus on the Northeast, North China and other regions, the company follows a development path of specialization, scale, and high-tech industrialization, achieving a dual harvest of enterprise value and social benefits.
The company is located in the Yuanbao Mountain Development Experimental Zone of Chifeng City, Inner Mongolia. The planned total area of the enterprise factory is 43333.54 square meters (65.00 acres), with a total construction area of 11567.92 square meters, a total capacity area of 23135.84 square meters, a plot ratio of 0.53, a building density of 66.33%, and administrative office and living facilities land accounting for 5.92%. The total investment is 130 billion yuan.
Product：api：DL-Thioctic acid、Palbociclib；pharmaceutical intermediates：3-Bromopyridine、5-Bromouracil、4-Chloro-2-fluorotoluene、tert-Butyl bromoacetate、2,3,4-Trihydroxybenzaldehyde、Bromothymol blue。